Treatment of restless legs syndrome/Willis-Ekbom disease with the non-selective ENT1/ENT2 inhibitor dipyridamole: testing the adenosine hypothesis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of restless legs syndrome/Willis-Ekbom disease with the non-selective ENT1/ENT2 inhibitor dipyridamole: testing the adenosine hypothesis

Published:2018-05 Issue: Volume:45 Page:94-97
ISSN:1389-9457
Container-title:Sleep Medicine
language:en
Short-container-title:Sleep Medicine

Author:

Garcia-Borreguero Diego,Guitart Xavier,Garcia Malo Celia,Cano-Pumarega Irene,Granizo Juan José,Ferré Sergi

Funder

intramural funds of the National Institute on Drug Abuse

Publisher

Elsevier BV

Subject

General Medicine

Reference19 articles.

1. Long-term use of pramipexole in the management of restless legs syndrome;Lipford;Sleep Med,2012

2. A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome;Silver;Sleep Med,2011

3. Natural course of restless legs syndrome/Willis-Ekbom disease: long-term observation of a large clinical cohort;Mitterling;Sleep Med,2015

4. Altered brain iron homeostasis and dopaminergic function in restless legs syndrome (Willis-Ekbom disease);Earley;Sleep Med,2014

5. Low brain iron effects and reversibility on striatal dopamine dynamics;Unger;Exp Neurol,2014

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and emerging pharmaceutical strategies for the treatment and management of restless legs syndrome;Expert Review of Neurotherapeutics;2024-07-31

2. Targeting Adenosine A2b Receptor Promotes Penile Rehabilitation of Refractory Erectile Dysfunction;Advanced Science;2024-06-14

3. Targeting the adenosinergic system in restless legs syndrome: A pilot, “proof-of-concept” placebo-controlled TMS-based protocol;PLOS ONE;2024-05-10

4. Dopamine Agonists in the Treatment of Restless Legs Syndrome: Too Much of a Good Thing?;Journal of Sleep Medicine;2024-04-30

5. A comprehensive update on the ADMET considerations for α2δ calcium channel ligand medications for treating restless legs syndrome;Expert Opinion on Drug Metabolism & Toxicology;2024-03-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3